ロード中...
Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease
PDE type 5 inhibitors (PDE5Is), such as sildenafil, tadalafil and vardenafil, are a class of drugs used to prolong the physiological effects of NO/cGMP signalling in tissues through the inhibition of cGMP degradation. Although these agents were originally developed for the treatment of hypertension...
保存先:
| 出版年: | Br J Pharmacol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7707100/ https://ncbi.nlm.nih.gov/pubmed/31721165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14920 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|